Hector Rodriguez-Villalobos
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Campylobacter rectus | 1 | 2018 | 2 | 0.75 | Why? |
| Campylobacter Infections | 1 | 2018 | 37 | 0.71 | Why? |
| Nontuberculous Mycobacteria | 1 | 2019 | 114 | 0.70 | Why? |
| Empyema, Pleural | 1 | 2018 | 46 | 0.69 | Why? |
| Chromatography, Affinity | 1 | 2019 | 310 | 0.65 | Why? |
| Mycobacterium Infections, Nontuberculous | 1 | 2019 | 167 | 0.63 | Why? |
| Enterobacteriaceae | 2 | 2019 | 395 | 0.63 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2019 | 449 | 0.41 | Why? |
| Belgium | 6 | 2021 | 2064 | 0.37 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.36 | Why? |
| Immunoassay | 3 | 2020 | 4485 | 0.35 | Why? |
| Carrier State | 1 | 2019 | 2100 | 0.32 | Why? |
| Feces | 1 | 2019 | 4235 | 0.28 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.28 | Why? |
| Prosthesis-Related Infections | 2 | 2018 | 302 | 0.26 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.24 | Why? |
| Hospitals, Teaching | 2 | 2021 | 1609 | 0.24 | Why? |
| Anti-Bacterial Agents | 7 | 2018 | 10083 | 0.24 | Why? |
| Bacteriological Techniques | 3 | 2018 | 239 | 0.23 | Why? |
| Pseudomonas aeruginosa | 2 | 2017 | 652 | 0.23 | Why? |
| Staphylococcus epidermidis | 2 | 2018 | 53 | 0.22 | Why? |
| Porins | 2 | 2017 | 45 | 0.20 | Why? |
| Mycobacterium chelonae | 1 | 2019 | 2 | 0.20 | Why? |
| Fusidic Acid | 1 | 2018 | 21 | 0.19 | Why? |
| Mycobacterium avium Complex | 1 | 2019 | 61 | 0.19 | Why? |
| Immunoenzyme Techniques | 1 | 2021 | 448 | 0.18 | Why? |
| Daptomycin | 1 | 2018 | 64 | 0.17 | Why? |
| Antibodies | 2 | 2021 | 846 | 0.17 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.17 | Why? |
| Tuberculosis, Osteoarticular | 1 | 2017 | 16 | 0.17 | Why? |
| Clostridiales | 1 | 2016 | 24 | 0.17 | Why? |
| Microbial Sensitivity Tests | 5 | 2018 | 2886 | 0.17 | Why? |
| Sensitivity and Specificity | 5 | 2021 | 22971 | 0.16 | Why? |
| Thienamycins | 1 | 2016 | 72 | 0.16 | Why? |
| Bacteria | 2 | 2018 | 1897 | 0.16 | Why? |
| DNA Primers | 1 | 2021 | 1170 | 0.16 | Why? |
| beta-Lactamases | 3 | 2019 | 759 | 0.16 | Why? |
| Blood Culture | 1 | 2018 | 308 | 0.15 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.15 | Why? |
| Aneurysm, False | 1 | 2016 | 88 | 0.15 | Why? |
| Arthritis, Infectious | 1 | 2017 | 111 | 0.15 | Why? |
| Penicillins | 1 | 2017 | 132 | 0.15 | Why? |
| Rectum | 1 | 2019 | 495 | 0.15 | Why? |
| Biofilms | 1 | 2018 | 304 | 0.15 | Why? |
| Pseudomonas Infections | 2 | 2017 | 425 | 0.15 | Why? |
| Osteomyelitis | 1 | 2017 | 131 | 0.14 | Why? |
| Automation, Laboratory | 1 | 2018 | 536 | 0.14 | Why? |
| Laboratories, Hospital | 1 | 2019 | 489 | 0.14 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.13 | Why? |
| Pneumonia, Bacterial | 2 | 2018 | 843 | 0.13 | Why? |
| Candida | 1 | 2018 | 425 | 0.13 | Why? |
| Aspergillosis | 1 | 2017 | 264 | 0.13 | Why? |
| Allografts | 1 | 2016 | 761 | 0.13 | Why? |
| Enterobacteriaceae Infections | 1 | 2019 | 529 | 0.12 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2016 | 323 | 0.12 | Why? |
| Candidiasis | 1 | 2017 | 334 | 0.12 | Why? |
| Aortic Diseases | 1 | 2016 | 362 | 0.12 | Why? |
| Opportunistic Infections | 1 | 2018 | 602 | 0.11 | Why? |
| Limit of Detection | 1 | 2019 | 2698 | 0.11 | Why? |
| Sputum | 1 | 2019 | 1720 | 0.11 | Why? |
| Bacterial Proteins | 1 | 2019 | 1318 | 0.10 | Why? |
| Immunity, Humoral | 2 | 2020 | 4849 | 0.09 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.09 | Why? |
| Reagent Kits, Diagnostic | 1 | 2019 | 2149 | 0.09 | Why? |
| Fatal Outcome | 1 | 2018 | 3438 | 0.09 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3633 | 0.08 | Why? |
| Orthopedic Procedures | 1 | 2018 | 1231 | 0.08 | Why? |
| Renal Dialysis | 2 | 2021 | 4358 | 0.08 | Why? |
| Cystic Fibrosis | 1 | 2017 | 1104 | 0.08 | Why? |
| Aminoglycosides | 1 | 2007 | 94 | 0.08 | Why? |
| Escherichia coli Proteins | 1 | 2007 | 168 | 0.08 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.08 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.07 | Why? |
| Occupational Exposure | 2 | 2021 | 4742 | 0.07 | Why? |
| Humans | 24 | 2021 | 930598 | 0.06 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Transplant Recipients | 1 | 2018 | 4982 | 0.06 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.05 | Why? |
| Methyltransferases | 1 | 2007 | 720 | 0.05 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.05 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.05 | Why? |
| Specimen Handling | 1 | 2018 | 6190 | 0.05 | Why? |
| Male | 11 | 2021 | 367725 | 0.05 | Why? |
| Aged | 7 | 2020 | 215776 | 0.05 | Why? |
| Rhodococcus | 1 | 2018 | 5 | 0.05 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.05 | Why? |
| Sonication | 1 | 2018 | 18 | 0.05 | Why? |
| Nocardia | 1 | 2018 | 21 | 0.05 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.05 | Why? |
| Mass Screening | 1 | 2019 | 8005 | 0.05 | Why? |
| Hip Prosthesis | 1 | 2018 | 54 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.04 | Why? |
| 1-Naphthylamine | 1 | 2017 | 1 | 0.04 | Why? |
| Sequence Analysis, DNA | 2 | 2016 | 2830 | 0.04 | Why? |
| Kidney Transplantation | 1 | 2018 | 5397 | 0.04 | Why? |
| Legionella | 1 | 2018 | 91 | 0.04 | Why? |
| Femur | 1 | 2018 | 100 | 0.04 | Why? |
| Bacterial Outer Membrane Proteins | 1 | 2017 | 60 | 0.04 | Why? |
| DNA, Ribosomal | 1 | 2016 | 112 | 0.04 | Why? |
| Polysaccharides, Bacterial | 1 | 2017 | 59 | 0.04 | Why? |
| Infant | 1 | 2020 | 30274 | 0.04 | Why? |
| Liquid Biopsy | 1 | 2017 | 114 | 0.04 | Why? |
| Biological Variation, Population | 1 | 2017 | 69 | 0.04 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2016 | 238 | 0.04 | Why? |
| Mycobacterium | 1 | 2018 | 143 | 0.04 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.04 | Why? |
| Rifampin | 1 | 2018 | 276 | 0.04 | Why? |
| Biological Transport | 1 | 2017 | 290 | 0.04 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.04 | Why? |
| Membrane Transport Proteins | 1 | 2017 | 152 | 0.04 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.04 | Why? |
| Luminescent Measurements | 1 | 2020 | 924 | 0.04 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| Blood Cell Count | 1 | 2020 | 1101 | 0.03 | Why? |
| Sequence Alignment | 1 | 2021 | 2109 | 0.03 | Why? |
| DNA Mutational Analysis | 1 | 2017 | 581 | 0.03 | Why? |
| Adult | 6 | 2021 | 244371 | 0.03 | Why? |
| Hemostasis | 1 | 2020 | 811 | 0.03 | Why? |
| Female | 8 | 2021 | 380317 | 0.03 | Why? |
| Infertility | 1 | 2017 | 247 | 0.03 | Why? |
| Body Fluids | 1 | 2018 | 451 | 0.03 | Why? |
| RNA, Ribosomal, 16S | 1 | 2016 | 793 | 0.03 | Why? |
| DNA, Bacterial | 1 | 2016 | 835 | 0.03 | Why? |
| Homes for the Aged | 1 | 2021 | 1071 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Child | 1 | 2020 | 70012 | 0.03 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 13720 | 0.03 | Why? |
| Animals | 1 | 2020 | 78931 | 0.03 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.03 | Why? |
| Family Characteristics | 1 | 2021 | 2551 | 0.03 | Why? |
| Lung | 1 | 2019 | 31049 | 0.03 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Temperature | 1 | 2018 | 2305 | 0.02 | Why? |
| Conjugation, Genetic | 1 | 2007 | 12 | 0.02 | Why? |
| Electrophoresis, Gel, Pulsed-Field | 1 | 2007 | 78 | 0.02 | Why? |
| Biomarkers | 2 | 2020 | 23361 | 0.02 | Why? |
| Antibody Formation | 1 | 2020 | 4038 | 0.02 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2016 | 1458 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Enzyme Inhibitors | 1 | 2016 | 1881 | 0.02 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| Immunologic Factors | 1 | 2021 | 4206 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2016 | 3788 | 0.02 | Why? |
| Kidney Failure, Chronic | 1 | 2021 | 3222 | 0.02 | Why? |
| Nurses | 1 | 2020 | 2285 | 0.02 | Why? |
| Nursing Homes | 1 | 2021 | 4155 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2016 | 6740 | 0.01 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.01 | Why? |
| Drug Resistance, Bacterial | 1 | 2007 | 1414 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Cross Infection | 1 | 2018 | 8675 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Coronavirus | 1 | 2021 | 18339 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |